Nutrien Ltd. Common Shares (NTR)

Total Costs & Expenses

$24.06B

TTM · Period ending: · USD

NTR logo

NTR Total Costs & Expenses

Latest reported$24.06B
NTR TTM Total Costs & Expenses ($191.40M → $24.06B)
High-resolution chart · PNG

NTR total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Nutrien Ltd. Common Shares Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
24,061,000,000
23,894,000,000
23,229,000,000
23,268,000,000
23,221,000,000
23,877,000,000
23,973,000,000
24,562,000,000
25,110,000,000
25,462,000,000
25,660,000,000
26,256,000,000
26,901,000,000
26,798,000,000
27,288,000,000
26,935,000,000
25,626,000,000
24,209,000,000
22,931,000,000
21,189,000,000
21,171,000,000
20,319,000,000
20,023,000,000
19,803,000,000
18,695,000,000
18,801,000,000
18,260,000,000
17,998,000,000
19,506,000,000
19,062,000,000
19,109,000,000
17,321,000,000
13,106,000,000
7,123,000,000
4,470,000,000
4,014,000,000
3,878,000,000
3,761,000,000
3,874,000,000
3,942,000,000
4,052,000,000
4,310,000,000
4,366,000,000
4,617,000,000
4,630,000,000
4,724,000,000
4,767,000,000
4,650,000,000
4,544,000,000
4,555,000,000
4,689,000,000
4,634,000,000
4,844,000,000
5,166,000,000
4,944,000,000
4,457,000,000
4,520,000,000
4,193,000,000
4,311,000,000
4,813,400,000
4,637,400,000
4,310,400,000
4,179,400,000
3,814,500,000
3,444,700,000
3,131,400,000
2,789,000,000
3,014,700,000
3,622,100,000
4,375,400,000
4,811,400,000
4,795,900,000
4,335,100,000
3,940,900,000
3,645,700,000
3,423,400,000
3,264,900,000
3,068,100,000
2,891,200,000
2,869,000,000
2,861,800,000
2,919,400,000
2,954,600,000
2,931,800,000
2,891,300,000
2,804,200,000
2,730,100,000
2,604,200,000
2,722,900,000
2,602,300,000
2,509,000,000
2,387,500,000
2,000,800,000
1,871,000,000
1,761,100,000
1,701,400,000
1,707,200,000
1,744,500,000
1,823,600,000
1,916,461,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.